Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A PDX1-ATF transcriptional complex governs β cell survival during stress.

Juliana CA, Yang J, Cannon CE, Good AL, Haemmerle MW, Stoffers DA.

Mol Metab. 2018 Nov;17:39-48. doi: 10.1016/j.molmet.2018.07.007. Epub 2018 Aug 1.

2.

The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys.

Lange HS, Cannon CE, Drott JT, Kuduk SD, Uslaner JM.

J Pharmacol Exp Ther. 2015 Dec;355(3):442-50. doi: 10.1124/jpet.115.226712. Epub 2015 Oct 7.

3.

Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey.

Vardigan JD, Cannon CE, Puri V, Dancho M, Koser A, Wittmann M, Kuduk SD, Renger JJ, Uslaner JM.

Psychopharmacology (Berl). 2015 Jun;232(11):1859-66. doi: 10.1007/s00213-014-3813-x. Epub 2014 Dec 10.

PMID:
25491927
4.

The Polycomb protein, Bmi1, regulates insulin sensitivity.

Cannon CE, Titchenell PM, Groff DN, El Ouaamari A, Kulkarni RN, Birnbaum MJ, Stoffers DA.

Mol Metab. 2014 Aug 27;3(8):794-802. doi: 10.1016/j.molmet.2014.08.002. eCollection 2014 Nov.

5.

The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey.

Eddins D, Hamill TG, Puri V, Cannon CE, Vivian JA, Sanabria-Bohórquez SM, Cook JJ, Morrow JA, Thomson F, Uslaner JM.

Psychopharmacology (Berl). 2014 Feb;231(3):511-9. doi: 10.1007/s00213-013-3260-0. Epub 2013 Sep 20.

PMID:
24051602
6.

Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition.

Uslaner JM, Tye SJ, Eddins DM, Wang X, Fox SV, Savitz AT, Binns J, Cannon CE, Garson SL, Yao L, Hodgson R, Stevens J, Bowlby MR, Tannenbaum PL, Brunner J, Mcdonald TP, Gotter AL, Kuduk SD, Coleman PJ, Winrow CJ, Renger JJ.

Sci Transl Med. 2013 Apr 3;5(179):179ra44. doi: 10.1126/scitranslmed.3005213.

7.

The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque.

Uslaner JM, Eddins D, Puri V, Cannon CE, Sutcliffe J, Chew CS, Pearson M, Vivian JA, Chang RK, Ray WJ, Kuduk SD, Wittmann M.

Psychopharmacology (Berl). 2013 Jan;225(1):21-30. doi: 10.1007/s00213-012-2788-8. Epub 2012 Jul 24.

PMID:
22825578
8.

The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey.

Smith SM, Uslaner JM, Cox CD, Huszar SL, Cannon CE, Vardigan JD, Eddins D, Toolan DM, Kandebo M, Yao L, Raheem IT, Schreier JD, Breslin MJ, Coleman PJ, Renger JJ.

Neuropharmacology. 2013 Jan;64:215-23. doi: 10.1016/j.neuropharm.2012.06.013. Epub 2012 Jun 27.

PMID:
22750078
9.

The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.

Cannon CE, Puri V, Vivian JA, Egbertson MS, Eddins D, Uslaner JM.

Neuropharmacology. 2013 Jan;64:191-6. doi: 10.1016/j.neuropharm.2012.05.003. Epub 2012 May 29.

PMID:
22659472
10.

Pcif1 modulates Pdx1 protein stability and pancreatic β cell function and survival in mice.

Claiborn KC, Sachdeva MM, Cannon CE, Groff DN, Singer JD, Stoffers DA.

J Clin Invest. 2010 Oct;120(10):3713-21. doi: 10.1172/JCI40440. Epub 2010 Sep 1.

11.

Plasmodium-infected Anopheles mosquitoes collected in Virginia and Maryland following local transmission of Plasmodium vivax malaria in Loudoun County, Virginia.

Robert LL, Santos-Ciminera PD, Andre RG, Schultz GW, Lawyer PG, Nigro J, Masuoka P, Wirtz RA, Neely J, Gaines D, Cannon CE, Pettit D, Garvey CW, Goodfriend D, Roberts DR.

J Am Mosq Control Assoc. 2005 Jun;21(2):187-93.

PMID:
16033121
13.

Department of Defense West Nile virus surveillance.

Cannon CE, Pavlin JA, Vaeth MF, Ludwig GV, Writer JV, Pagac BB, Goldenbaum MB, Kelley PW.

Ann N Y Acad Sci. 2001 Dec;951:340-2. No abstract available.

PMID:
11797794
14.

A point-mass model of gibbon locomotion.

Bertram JE, Ruina A, Cannon CE, Chang YH, Coleman MJ.

J Exp Biol. 1999 Oct;202(Pt 19):2609-17.

15.

Current therapies for secondary prevention after myocardial infarction.

Cannon CE, Smith SC Jr.

Curr Opin Cardiol. 1999 Mar;14(2):155-60.

PMID:
10191975
16.

Surface roughness, porosity, and texture as modifiers of cellular adhesion.

Recum AF, Shannon CE, Cannon CE, Long KJ, Kooten TG, Meyle J.

Tissue Eng. 1996 Winter;2(4):241-53. doi: 10.1089/ten.1996.2.241.

PMID:
19877956
17.
18.
19.

Supplemental Content

Loading ...
Support Center